Biologics News
-
Duke-NUS researchers reveal novel immune study on dengue
Biologics | News | 0 Comment | 08 Feb, 2019
Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of ...Read more
-
NUS researchers study nanoparticles’ role in cancer metastasis
Biologics | News | 0 Comment | 04 Feb, 2019
Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medic...Read more
-
Researchers in Japan develop strategy to strengthen skeletal muscles
Biologics | News | 1 Comment | 01 Feb, 2019
Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...Read more
-
Alvotech raises $300mn to further biosimilar development
Biologics | News | 0 Comment | 24 Jan, 2019
Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...Read more
-
Novel device by NUS aids in muscle recovery
Biologics | News | 2 Comment | 24 Jan, 2019
A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle reh...Read more
-
I-Mab Biopharma gets USFDA IND nod for antibody TJD5
Biologics | News | 0 Comment | 23 Jan, 2019
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...Read more
-
Mechanical stress may affect normal bone development
Biologics | News | 0 Comment | 21 Jan, 2019
The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...Read more
-
Branched-Chain amino acids can regulate progression of Cancer: Research
Biologics | News | 0 Comment | 21 Jan, 2019
Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) i...Read more
-
Ribon Therapeutics raises $65M
Biologics | News | 0 Comment | 07 Jan, 2019
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...Read more
-
Tizona Therapeutics appoints Scott Clarke as CEO
Biologics | News | 0 Comment | 05 Jan, 2019
US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief execut...Read more
-
Betta Pharma uses ProBioGen's technology for cancer treatment
Biologics | News | 0 Comment | 03 Jan, 2019
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...Read more
-
Roswell Biotech secures $32 million series A financing round
Biologics | News | 0 Comment | 03 Jan, 2019
Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA Sequencing, ha...Read more
-
Innovent, Eli Lilly announce co-development of Tyvyt
Biologics | News | 0 Comment | 28 Dec, 2018
Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...Read more
-
Researchers discover new compound to treat breast cancer
Biologics | News | 0 Comment | 13 Dec, 2018
A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...Read more
-
Gilead names Daniel O’Day as Chairman and CEO
Biologics | News | 0 Comment | 11 Dec, 2018
Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...Read more
-
Trianni, MacroGenics enter into a license agreement
Biologics | News | 0 Comment | 08 Dec, 2018
Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...Read more
-
Australian researchers develop novel technology for cancer detection
Biologics | News | 0 Comment | 05 Dec, 2018
A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...Read more
-
Marmosets viable in vivo models for developing immune-based therapies
Biologics | News | 0 Comment | 26 Nov, 2018
Singapore – Scientists from A*STAR’s Singapore Immunology Network (SIgN) and Singapore Bioimaging Consortium...Read more
